Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-24 @ 2:12 PM
NCT ID:
NCT03974295
Eligibility Criteria:
Inclusion Criteria:
* female fertility patients having frozen embryo transfer
* programmed hormone replacement (Oral Estrace, Vivelle dot (patch), intravenous Estradiol) with and without gonadotrophin releasing hormone analogue pretreatment and some form of parenteral progesterone supplementation (daily or every 3 days intramuscular Progesterone) for luteal support
Exclusion Criteria:
* unable to provide informed consent
* not undergoing programmed hormone replacement for frozen embryo transfer (natural cycle frozen embryo transfer)
* undergoing fresh embryo transfer
* not able to engage in heterosexual intercourse (same sex couple, partner with severe sexual dysfunction)
* cannot undergo unprotected vaginal intercourse (infected with hepatitis B, C, or human immunodeficiency virus).
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT03974295
Study Brief:
Protocol Section:
NCT03974295